tiprankstipranks
Eupraxia Pharmaceuticals (EPRX)
NASDAQ:EPRX
US Market
EPRX
Eupraxia Pharmaceuticals
RESEARCH TOOLSreports
Want to see EPRX full AI Analyst Report?

Eupraxia Pharmaceuticals (EPRX) Stock News & Sentiment

36 Followers
Eupraxia Pharmaceuticals Posts Strong Histologic Gains in Mid-Stage EoE Trial for EP-104GI
Premium
Company Announcements
Eupraxia Pharmaceuticals Posts Strong Histologic Gains in Mid-Stage EoE Trial for EP-104GI
2d ago
6K
EPRX
Eupraxia Pharmaceuticals Highlights Strong EP-104GI EoE Data From RESOLVE Trial at DDW
Premium
Company Announcements
Eupraxia Pharmaceuticals Highlights Strong EP-104GI EoE Data From RESOLVE Trial at DDW
3d ago
6K
EPRX
Buy Rating Backed by Favorable Safety and Promising Efficacy Data for EP-104GI in Eosinophilic Esophagitis
Premium
Ratings
Buy Rating Backed by Favorable Safety and Promising Efficacy Data for EP-104GI in Eosinophilic Esophagitis
4d ago
EPRX
Eupraxia Pharmaceuticals Names New Chief Medical Officer to Steer Late-Stage Pipeline
Premium
Company Announcements
Eupraxia Pharmaceuticals Names New Chief Medical Officer to Steer Late-Stage Pipeline
6d ago
6K
EPRX
Eupraxia Pharmaceuticals to Showcase EP-104GI Data at Digestive Disease Week 2026
Premium
Company Announcements
Eupraxia Pharmaceuticals to Showcase EP-104GI Data at Digestive Disease Week 2026
16d ago
6K
EPRX
Eupraxia Pharmaceuticals: Strong EP-104GI Clinical Durability and Dose-Response Support Buy Rating and Favorable Risk-Reward
Premium
Ratings
Eupraxia Pharmaceuticals: Strong EP-104GI Clinical Durability and Dose-Response Support Buy Rating and Favorable Risk-Reward
16d ago
EPRX
Eupraxia Posts Strong 36-Week EoE Data From Highest-Dose Cohort in RESOLVE Trial
Premium
Company Announcements
Eupraxia Posts Strong 36-Week EoE Data From Highest-Dose Cohort in RESOLVE Trial
17d ago
6K
EPRX
More EPRX News >

EPRX News on the Web

Eupraxia Pharmaceuticals to Highlight Drug-Delivery Pipeline at April Investor Conferences
TipRanks News
Neutral
New Strong Sell Stocks for April 2nd
Zacks
Bearish
Eupraxia Pharmaceuticals (EPRX) Receives a Buy from Cantor Fitzgerald
TipRanks News
Bullish
Eupraxia Pharmaceuticals: Underdiagnosed EoE Market Expands Upside, Supporting Buy Rating on EPRX
TipRanks News
Bullish
Eupraxia Pharmaceuticals initiated with an Outperform at William Blair
TipRanks News
Bullish
Eupraxia: Differentiated Once-Yearly EoE Therapy and Platform Expansion Support Buy Rating
TipRanks News
Bullish
Eupraxia Pharmaceuticals (EPRX) Receives a Rating Update from a Top Analyst
TipRanks News
Bullish
Eupraxia Pharmaceuticals: Durable EP-104GI Data and Upcoming Catalysts Support Buy Rating
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
EPRX
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is EPRX’s Media Buzz Sentiment?
1 articles about EPRX were published this week. In an average week, 1 articles are published.
    What is EPRX’s weekly average amount of articles?
    In an average week, 1 articles about EPRX are published.
      What is EPRX’s News Sentiment?
      50% of articles about EPRX were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week